期刊文献+

2型糖尿病微血管并发症与非高密度脂蛋白胆固醇关系的临床研究 被引量:5

Study of relationship between non-HDL-C and microvascular complications with type 2 diabetes meUitus
下载PDF
导出
摘要 目的探讨非高密度脂蛋白胆固醇与2型糖尿病微血管并发症的关系及临床价值。方法选择2型糖尿病患者120例,并将其分为糖尿病无血管并发症组60例(B组)和糖尿病微血管并发症组60例(c组),另选择正常对照组100例(A组),检测各组血脂并计算非高密度脂蛋白胆固醇(non-HDL—C)。结果A组、B组、C组non—HDL—C水平依次升高,且差异有统计学意义(P〈0.05);运用ROC曲线对B组、C组的血脂指标进行分析显示,non—HDL—C的曲线下面积最大,为0.638,且两组间比较差异有统计学意义(P〈0.05),临床应用价值较大。结论non—HDL—C的增高是糖尿病微血管并发症的危险因素,有较高的临床应用价值。 Objective To explore the relationship of non-HDL-C and microvascular complications with type 2 diabetes mellitus and analyze the clinical application value of non-HDL-C. Methods 120 patients with T2DM were enrolled in the study:60 patients without mirovascular complications (group B), 60 patients with microvascular complications ( group C ), meanwhile 100 individuals as normal controls ( group A). Blood lipids were measured and non-HDL-C was calculated. Results The level of non-HDL-C was successively increased in group A, B and C, and there was significant difference among these three groups (P 〈 0.05) ; Using ROC curve to analyze the clinical application value of non-HDL-C in patients with microvascular complications of T2DM, we found that compared with group B, non-HDL-C had the largest area undercurve of 0.638 in group C and had significant difference ( P 〈 0.05 ). Conclusion The increase of non- HDL-C was the risk factor for microascular complications of T2DM and had high clinical application value.
出处 《临床内科杂志》 CAS 2010年第2期99-101,共3页 Journal of Clinical Internal Medicine
关键词 2型糖尿病 微血管并发症 非高密度脂蛋白胆固醇 脂代谢异常 Type 2 diabetes mellitus Microvacular comphcations Non-HDL-C Dyslipidemia
  • 相关文献

参考文献7

二级参考文献55

  • 1李健斋,王抒,曾平.非高密度脂蛋白胆固醇用于评估及预测冠心病危险[J].中华心血管病杂志,2004,32(11):963-966. 被引量:45
  • 2魏有仁,侯林浦,王玫,湛玉良,朱立华.尿中微量白蛋白的测定及应用[J].生物化学与生物物理进展,1995,22(2):169-173. 被引量:84
  • 3张代民,张莹,许会彬.糖尿病肾病患者血清甘油三酯的变化[J].国外医学(临床生物化学与检验学分册),2005,26(12):956-957. 被引量:7
  • 4Chew EY, Klein ML, Ferris FL, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy.Early Treatment Diabetic Retinopathy Study(ETDRS) Report 22.Arch Ophthalmol, 1996, 114:1079-1084.
  • 5Kohner EM, Aldington SJ, Stratton IM. United Kingdom prospective diabetes study, 30: diabetic retinopathy at diagnosis of non - insulin - dependent diabetes mellitus and associated risk factors. Arch Ophthalnol, 1998, 116:297-303.
  • 6Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. Ⅱ: Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol, 1984, 102:520-526.
  • 7Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. ⅩⅦ. The 14 - year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology, 1998, 105:1801-1815.
  • 8Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. Ⅲ: Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol, 1984, 102:527-532.
  • 9Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. Ⅸ: Four - year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol , 1989, 107: 237-243.
  • 10Klein BEK, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care, 1990, 13: 34-40.

共引文献295

同被引文献89

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部